Effective Method To Prevent DVT Following Joint Replacemement Surgery Devised

Following joint replacement surgery, a team of efficient scientists including some from Oklahoma, Denmark, Australia and Canada, has found a better way to prevent deadly blood clots.

Blood clots, known as deep-vein thrombosis (DVT), affect the large veins in the lower leg and thigh.

ATryn Effectively Prevents Serious Blood Clots, Says Research
ATryn® or Antithrombin Recombinant safely prevents peri-operative and peri-partum acute deep vein thrombosis (DVT) in patients with hereditary antithrombin deficiency

If the clot breaks free and moves through the bloodstream, it can lodge in the lungs, a condition known as pulmonary embolism (PE), which is often fatal.

Current preventive treatments include uncomfortable injections and one oral anti-clotting medicine that are difficult for patients and physicians to manage.

The research team, therefore, set out to find a better way to prevent blood clots without increasing the risk of bleeding.

Long Flights Linked to High Risk of Blood Clots
A review of previous studies by researchers at the Harvard School of Public Health in Boston has said that long flights increase the risk of potentially fatal blood clots.

In a double-blind study of more than 3,000 patients, researchers tested a new type of anti-clotting drug called Apixaban, which is an oral medication.

The medicine proved just as effective at preventing blood clots and reduced the risk of bleeding by half.

New Study Shows Sun Exposure Reduces Risk of Blood Clots
While sun exposure has long been linked to skin cancer, a new Swedish study shows it also dramatically reduces the risk of suffering blood clots, one of the authors of the report said on Wednesday.

"This is a major step in our fight to prevent DVT and the many unnecessary deaths each year caused by blood clots after joint replacement surgery. We now have a better treatment that reduces the risk of bleeding, and a patient no longer has to endure injections by needle," said Gary Raskob, Ph.D., a lead researcher on the project and dean of the University of Oklahoma College of Public Health.

Apixaban is now being studied in Phase III clinical trials and, if approved by the U.S. Food and Drug Administration, will be an important option for patients having joint replacement surgery.

Investigational Drug Proves Safe in Preventing Blood Clots
A new drug derived from magnolia trees appears to be able to uncouple two important functions of thrombin in blood clot formation and may offer a way to better control.

The research appears this week in the New England Journal of Medicine.

Source-ANI
TAN